Scientists supercharge Patients' own immune cells to fight advanced cancer
Disease control
Ongoing
This is a first-in-human study testing a new personalized cell therapy for people with advanced solid tumors that have not responded to standard treatments. Doctors take a patient's own tumor-fighting immune cells from a tumor sample, grow large numbers of the most potent ones in…
Phase: PHASE1 • Sponsor: AgonOx, Inc. • Aim: Disease control
Last updated Mar 25, 2026 14:08 UTC